John T. Curnutte
2014
In 2014, John T. Curnutte earned a total compensation of $1.9M as Executive Vice President, Research and Development at Portola Pharmaceuticals, a 188% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $153,720 |
|---|---|
| Option Awards | $1,280,918 |
| Salary | $401,880 |
| Other | $26,142 |
| Total | $1,862,660 |
Curnutte received $1.3M in option awards, accounting for 69% of the total pay in 2014.
Curnutte also received $153.7K in non-equity incentive plan, $401.9K in salary and $26.1K in other compensation.
Rankings
In 2014, John T. Curnutte's compensation ranked 4,801st out of 13,032 executives tracked by ExecPay. In other words, Curnutte earned more than 63.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,801 out of 13,032 | 63rd |
Division Manufacturing | 1,716 out of 4,965 | 65th |
Major group Chemicals And Allied Products | 563 out of 1,690 | 67th |
Industry group Drugs | 430 out of 1,369 | 69th |
Industry Pharmaceutical Preparations | 342 out of 1,042 | 67th |
Source: SEC filing on April 24, 2017.
Curnutte's colleagues
We found two more compensation records of executives who worked with John T. Curnutte at Portola Pharmaceuticals in 2014.